315 related articles for article (PubMed ID: 26449597)
1. Aglycemia keeps mitochondrial oxidative phosphorylation under hypoxic conditions in HepG2 cells.
Plecitá-Hlavatá L; Ježek J; Ježek P
J Bioenerg Biomembr; 2015 Dec; 47(6):467-76. PubMed ID: 26449597
[TBL] [Abstract][Full Text] [Related]
2. Aglycemic HepG2 Cells Switch From Aminotransferase Glutaminolytic Pathway of Pyruvate Utilization to Complete Krebs Cycle at Hypoxia.
Ježek J; Plecitá-Hlavatá L; Ježek P
Front Endocrinol (Lausanne); 2018; 9():637. PubMed ID: 30416487
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial oxidative phosphorylation became functional under aglycemic hypoxia conditions in A549 cells.
Öğünç Keçeci Y; İncesu Z
Mol Biol Rep; 2022 Sep; 49(9):8219-8228. PubMed ID: 35834035
[TBL] [Abstract][Full Text] [Related]
4. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells.
Dai Q; Yin Q; Wei L; Zhou Y; Qiao C; Guo Y; Wang X; Ma S; Lu N
Mol Carcinog; 2016 Aug; 55(8):1275-89. PubMed ID: 26259145
[TBL] [Abstract][Full Text] [Related]
5. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells.
Zimmer AD; Walbrecq G; Kozar I; Behrmann I; Haan C
Hypoxia (Auckl); 2016; 4():135-145. PubMed ID: 27800515
[TBL] [Abstract][Full Text] [Related]
7. Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development.
Jezek P; Plecitá-Hlavatá L; Smolková K; Rossignol R
Int J Biochem Cell Biol; 2010 May; 42(5):604-22. PubMed ID: 19931409
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53
Hernández-Reséndiz I; Gallardo-Pérez JC; López-Macay A; Robledo-Cadena DX; García-Villa E; Gariglio P; Saavedra E; Moreno-Sánchez R; Rodríguez-Enríquez S
J Cell Physiol; 2019 May; 234(5):5524-5536. PubMed ID: 30272821
[TBL] [Abstract][Full Text] [Related]
9. Glucose plays a main role in human fibroblasts adaptation to hypoxia.
Baracca A; Sgarbi G; Padula A; Solaini G
Int J Biochem Cell Biol; 2013 Jul; 45(7):1356-65. PubMed ID: 23538299
[TBL] [Abstract][Full Text] [Related]
10. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells.
Hsu CC; Wang CH; Wu LC; Hsia CY; Chi CW; Yin PH; Chang CJ; Sung MT; Wei YH; Lu SH; Lee HC
Biochim Biophys Acta; 2013 Oct; 1830(10):4743-51. PubMed ID: 23791554
[TBL] [Abstract][Full Text] [Related]
12. Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma.
Rodríguez-Enríquez S; Carreño-Fuentes L; Gallardo-Pérez JC; Saavedra E; Quezada H; Vega A; Marín-Hernández A; Olín-Sandoval V; Torres-Márquez ME; Moreno-Sánchez R
Int J Biochem Cell Biol; 2010 Oct; 42(10):1744-51. PubMed ID: 20654728
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.
Yang Y; Zhang G; Guo F; Li Q; Luo H; Shu Y; Shen Y; Gan J; Xu L; Yang H
Cell Rep; 2020 Nov; 33(5):108340. PubMed ID: 33147459
[TBL] [Abstract][Full Text] [Related]
14. Chronic hypoxia leads to a glycolytic phenotype and suppressed HIF-2 signaling in PC12 cells.
Zhdanov AV; Dmitriev RI; Golubeva AV; Gavrilova SA; Papkovsky DB
Biochim Biophys Acta; 2013 Jun; 1830(6):3553-69. PubMed ID: 23462283
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
Maher JC; Wangpaichitr M; Savaraj N; Kurtoglu M; Lampidis TJ
Mol Cancer Ther; 2007 Feb; 6(2):732-41. PubMed ID: 17308069
[TBL] [Abstract][Full Text] [Related]
16. Melanoma tumors exhibit a variable but distinct metabolic signature.
Feichtinger RG; Lang R; Geilberger R; Rathje F; Mayr JA; Sperl W; Bauer JW; Hauser-Kronberger C; Kofler B; Emberger M
Exp Dermatol; 2018 Feb; 27(2):204-207. PubMed ID: 29131438
[TBL] [Abstract][Full Text] [Related]
17. Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells.
Huang CY; Kuo WT; Huang YC; Lee TC; Yu LC
Cell Death Dis; 2013 May; 4(5):e622. PubMed ID: 23640464
[TBL] [Abstract][Full Text] [Related]
18. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.
Kim JW; Tchernyshyov I; Semenza GL; Dang CV
Cell Metab; 2006 Mar; 3(3):177-85. PubMed ID: 16517405
[TBL] [Abstract][Full Text] [Related]
19. Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.
Lai JH; Jan HJ; Liu LW; Lee CC; Wang SG; Hueng DY; Cheng YY; Lee HM; Ma HI
Neuro Oncol; 2013 Oct; 15(10):1330-41. PubMed ID: 23911596
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships].
Liu KG; Xie HH; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
